Richard Twomey appointed New CEO
Richard Twomey to succeed Pierre Guyot as CEO of Mölnlycke Health Care
April 24 2014
Mölnlycke Health Care today announces that Richard Twomey has been appointed Chief Executive Officer (CEO). Richard will join the Company on 1 February 2014 and assumes the role of CEO on 1 April 2014. Richard succeeds Pierre Guyot, who has led Mölnlycke Health Care since 2007. Pierre will remain with the Company until Richard assumes his new role, in order to ensure a smooth transitional period.
Gunnar Brock, Chairman of Mölnlycke Health Care, says:
“I am very glad to welcome Richard Twomey, who has a solid med-tech background and strong track-record in leading growing businesses. I would also like to thank Pierre for his excellent contribution during his seven years as CEO. During this period, Mölnlycke Health Care has seen a very successful development in terms of growth and profitability, and the company has grown into an undisputed leader in many of its markets.”
Börje Ekholm, President and CEO of Investor AB, says:
“I believe that Richard Twomey is a great recruitment, and his knowledge and expertise will truly benefit Mölnlycke Health Care going forward. I would like to thank Pierre for his highly successful work in making Mölnlycke Health Care a leading company in its field. During his leadership, the Company has evolved from a rather local player with focus on Northern Europe into an international leader in a very competitive market.”
A Welsh national, Richard Twomey is currently International Vice President of the California-based orthodontics company Align Technology and previously held a number of senior positions within divisions of Johnson & Johnson and as President of DePuy, International Ltd.
Headquartered in Göteborg, Sweden, Mölnlycke Health Care’s history dates back to 1849. The Company became independent in 1997 and since 2007 is majority-owned by Investor AB. The Company has over 7,400 employees across over 30 countries.